Boehringer Ingelheim vaccinates over 100 billion birds with VAXXITEK since 2006

Boehringer Ingelheim vaccinates over 100 billion birds with VAXXITEK ® HVT + IBD since 2006VAXXITEK ® HVT + IBD provides a life-long immunity against Infectious bursal disease and Marek ' s diseaseIt is the first vector vaccine to have been launched on the avian marketVAXXITEK ® HVT + IBD is registered in more than 75 countries 

Source: Boehringer Ingelheim Corporate News - December 12, 2018 Category: Research Source Type: news